Literature DB >> 3559725

Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.

J J Olson, D W Beck, J A Schlechte, P M Loh.   

Abstract

Meningiomas have been shown to have steroid-binding proteins. In vitro, estradiol, progesterone, and the antiestrogen tamoxifen stimulate tumor growth. However, incubation of tumor cells with an antiprogesterone agent results in tumor inhibition. In this investigation, a human meningioma was implanted subcutaneously in athymic nude mice. Two treatment groups were established, one receiving the antiprogesterone agent RU-38486 (10 mg/kg/day in suspension) and the other receiving only vehicle. After 3 months, the tumor growth index (defined as the tumor volume at 3 months divided by the initial tumor volume) was 0.25 +/- 0.46 (mean +/- standard deviation) in the group receiving antiprogesterone and was 1.54 +/- 0.58 in the control group (p = 0.041). Further investigation of the effect of antiprogestational agents on the growth and hormone-binding proteins of other meningiomas will better define the mechanism of their effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559725     DOI: 10.3171/jns.1987.66.4.0584

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  18 in total

1.  Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2.

Authors:  Kyoung-Jin Min; Ji Hoon Jang; Jung Tae Lee; Kyeong Sook Choi; Taeg Kyu Kwon
Journal:  J Mol Med (Berl)       Date:  2011-10-19       Impact factor: 4.599

2.  Immunocytochemical study of progesterone receptor in human meningioma.

Authors:  M Perrot-Applanat; M T Groyer-Picard; M Kujas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 3.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

4.  Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma.

Authors:  S M Grunberg; M H Weiss
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

5.  Characterization of the influence of anti-hormone and/or anti-growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines.

Authors:  I Camby; I Salmon; S Rorive; T Gras; F Darro; A Kruczynski; A Danguy; J L Pasteels; R Kiss
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  Orbital meningiomas: surgery, radiotherapy, or hormones?

Authors:  G E Rose
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

Review 7.  Meningioma mouse models.

Authors:  Michel Kalamarides; Matthieu Peyre; Marco Giovannini
Journal:  J Neurooncol       Date:  2010-08-24       Impact factor: 4.130

8.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

9.  Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

Authors:  T Yazaki; Y Takamiya; P C Costello; T Mineta; A G Menon; S D Rabkin; R L Martuza
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 10.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.